| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Executive Vice President & CFO | Restricted Stock Units | 640,042 | $1,907,553 | $4.01 | 21 Nov 2025 | Direct |
| AMARIN CORP PLC\UK | SVP and CFO | Ordinary Shares | 337,314 | $367,672 | $1.09 | 01 Aug 2022 | Direct |
| CATALYST PHARMACEUTICALS, INC. | Executive Vice President & CFO | Common Stock, par value $0.001 per share | 8,606 | $184,426 | $21.43 | 21 Nov 2025 | Direct |
| CATALYST PHARMACEUTICALS, INC. | Executive Vice President & CFO | Options to purchase common stock | 607,235 | 20 Nov 2025 | Direct | ||
| IMPEL PHARMACEUTICALS INC | CFO | Stock Option (right to buy) | 175,000 | 10 May 2023 | Direct | ||
| AMARIN CORP PLC\UK | SVP and CFO | Restricted Stock Units | 95,533 | 29 Jul 2022 | Direct | ||
| IMPEL PHARMACEUTICALS INC | CFO | Restricted Stock Units (RSUs) | 47,500 | 10 May 2023 | Direct | ||
| CinCor Pharma, Inc. | EVP & Chief Financial Officer | Common Stock | 0 | $28.75 | 24 Feb 2023 | Direct | |
| CinCor Pharma, Inc. | EVP & Chief Financial Officer | Stock Option (Right to Buy) | 0 | 24 Feb 2023 | Direct | ||
| IMPEL PHARMACEUTICALS INC | CFO | No securities beneficially held. | 0 | 10 May 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CPRX | CATALYST PHARMACEUTICALS, INC. | 20 Nov 2025 | 5 | $0 | 4 | Executive Vice President & CFO | 24 Nov 2025, 20:08 |
| CPRX | CATALYST PHARMACEUTICALS, INC. | 02 Jan 2025 | 3 | $0 | 4 | Executive Vice President & CFO | 03 Jan 2025, 17:00 |
| CPRX | CATALYST PHARMACEUTICALS, INC. | 21 Nov 2024 | 2 | $0 | 4 | Executive Vice President & CFO | 25 Nov 2024, 17:01 |
| CPRX | CATALYST PHARMACEUTICALS, INC. | 01 Jan 2024 | 0 | $0 | 3 | Executive Vice President & CFO | 03 Jan 2024, 17:18 |
| IMPL | IMPEL PHARMACEUTICALS INC | 10 May 2023 | 2 | $0 | 4 | CFO | 12 May 2023, 16:41 |
| IMPL | IMPEL PHARMACEUTICALS INC | 10 May 2023 | 0 | $0 | 3 | CFO | 12 May 2023, 16:22 |
| CINC | CinCor Pharma, Inc. | 24 Feb 2023 | 2 | $0 | 4 | EVP & Chief Financial Officer | 24 Feb 2023, 17:38 |
| CINC | CinCor Pharma, Inc. | 26 Jan 2023 | 1 | $0 | 4 | EVP & Chief Financial Officer | 30 Jan 2023, 19:04 |
| CINC | CinCor Pharma, Inc. | 04 Nov 2022 | 2 | $0 | 4 | EVP & Chief Financial Officer | 08 Nov 2022, 16:08 |
| CINC | CinCor Pharma, Inc. | 04 Nov 2022 | 0 | $0 | 3 | EVP & Chief Financial Officer | 08 Nov 2022, 16:06 |
| AMRN | AMARIN CORP PLC\UK | 29 Jul 2022 | 4 | $-62,380 | 4 | SVP and CFO | 02 Aug 2022, 20:07 |
| AMRN | AMARIN CORP PLC\UK | 28 Feb 2022 | 3 | $-20,317 | 4 | SVP and CFO | 02 Mar 2022, 19:03 |
| AMRN | AMARIN CORP PLC\UK | 04 Feb 2022 | 2 | $0 | 4 | SVP and CFO | 08 Feb 2022, 19:05 |
| AMRN | AMARIN CORP PLC\UK | 31 Jan 2022 | 3 | $-17,865 | 4 | SVP and CFO | 02 Feb 2022, 19:03 |
| AMRN | AMARIN CORP PLC\UK | 31 Dec 2021 | 3 | $-85,020 | 4 | SVP and CFO | 04 Jan 2022, 20:08 |
| AMRN | AMARIN CORP PLC\UK | 31 Aug 2021 | 7 | $-16,681 | 4 | SVP and CFO | 02 Sep 2021, 20:04 |
| AMRN | AMARIN CORP PLC\UK | 12 Aug 2021 | 5 | $-348,440 | 4 | SVP and CFO | 13 Aug 2021, 20:04 |
| AMRN | AMARIN CORP PLC\UK | 02 Aug 2021 | 1 | $0 | 4 | SVP and CFO | 04 Aug 2021, 20:05 |
| AMRN | AMARIN CORP PLC\UK | 30 Jul 2021 | 7 | $-12,466 | 4 | SVP and CFO | 03 Aug 2021, 20:10 |
| AMRN | AMARIN CORP PLC\UK | 30 Jun 2021 | 7 | $-13,489 | 4 | SVP and CFO | 02 Jul 2021, 20:11 |
| AMRN | AMARIN CORP PLC\UK | 28 May 2021 | 7 | $-13,597 | 4 | SVP and CFO | 28 May 2021, 20:06 |